Matisse Capital
- SEC CIK
- 0001668256
- Latest filing
- Aug 12, 2026
FULC holding history
Fulcrum Therapeutics, Inc. in every 13F filed by Matisse Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FULC overviewAll 13F holders of FULCFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −39,649−100.0% | Sold out | Holders |
| Q1 2026 | 39,649 | $304.1K | 0.1% | +26,189+194.6% | Added | Holders |
| Q4 2025 | 13,460 | $152.2K | 0.1% | −5,170−27.8% | Reduced | Holders |
| Q3 2025 | 18,630 | $171.4K | 0.1% | −7,470−28.6% | Reduced | Holders |
| Q2 2025 | 26,100 | $179.6K | 0.1% | −70,617−73.0% | Reduced | Holders |
| Q1 2025 | 96,717 | $278.5K | 0.1% | −31,728−24.7% | Reduced | Holders |
| Q4 2024 | 128,445 | $603.7K | 0.3% | +21,728+20.4% | Added | Holders |
| Q3 2024 | 106,717 | $381.0K | 0.2% | +106,717 | New | Holders |